SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+10.66%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$239M
AUM Growth
+$239M
(+21%)
Cap. Flow
+$24.1M
Cap. Flow
% of AUM
10.07%
Top 10 Holdings %
Top 10 Hldgs %
39.46%
Holding
44
New
11
Increased
12
Reduced
7
Closed
5
Top Buys
| 1 |
Biogen
BIIB
|
$6.47M |
| 2 |
Abbott
ABT
|
$5.78M |
| 3 |
Inspire Medical Systems
INSP
|
$5.59M |
| 4 |
Smith & Nephew
SNN
|
$5.18M |
| 5 |
DaVita
DVA
|
$4.71M |
Top Sells
| 1 |
Baxter International
BAX
|
$4.72M |
| 2 |
Avantor
AVTR
|
$3.79M |
| 3 |
CTLT
CATALENT, INC.
CTLT
|
$3.64M |
| 4 |
IQVIA
IQV
|
$3.44M |
| 5 |
Cencora
COR
|
$3.08M |
Sector Composition
| 1 | Healthcare | 94.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
SPDR S&P Biotech ETF
XBI
$5.07B
| $12.1M | 5.06% | 135,588 +35,588 | +36% | +$3.18M |
|
2
Tenet Healthcare
THC
$16.3B
| $11M | 4.58% | 145,000 +5,000 | +4% | +$378K |
|
3
HCA Healthcare
HCA
$94.5B
| $10.8M | 4.52% | 40,000 | – | – |
|
4
Universal Health Services
UHS
$11.6B
| $10.3M | 4.3% | 67,500 +2,500 | +4% | +$381K |
|
5
Novo Nordisk
NVO
$251B
| $9.31M | 3.89% | 90,000 | – | – |
|
6
Boston Scientific
BSX
$156B
| $9.25M | 3.86% | 160,000 | – | – |
|
7
Eli Lilly
LLY
$657B
| $8.74M | 3.65% | 15,000 | – | – |
|
8
Stryker
SYK
$150B
| $8.39M | 3.5% | 28,000 +500 | +2% | +$150K |
|
9
Intuitive Surgical
ISRG
$170B
| $7.59M | 3.17% | 22,500 | – | – |
|
10
Acadia Healthcare
ACHC
$2.12B
| $7M | 2.92% | 90,000 +15,000 | +20% | +$1.17M |
|
11
McKesson
MCK
$85.4B
| $6.95M | 2.9% | 15,000 -2,500 | -14% | -$1.16M |
|
12
Humana
HUM
$36.5B
| $6.87M | 2.87% | 15,000 -2,500 | -14% | -$1.14M |
|
13
Medtronic
MDT
$119B
| $6.59M | 2.75% | 80,000 | – | – |
|
|
14
Biogen
BIIB
$19.4B
| $6.47M | 2.7% | +25,000 | New | +$6.47M |
|
15
Surgery Partners
SGRY
$2.91B
| $6.4M | 2.67% | 200,000 +25,000 | +14% | +$800K |
|
16
Thermo Fisher Scientific
TMO
$186B
| $6.37M | 2.66% | 12,000 +1,500 | +14% | +$796K |
|
17
DexCom
DXCM
$29.5B
| $6.21M | 2.59% | 50,000 | – | – |
|
18
Zimmer Biomet
ZBH
$21B
| $6.09M | 2.54% | 50,000 | – | – |
|
19
Encompass Health
EHC
$12.3B
| $6.01M | 2.51% | 90,000 | – | – |
|
20
Select Medical
SEM
$1.61B
| $5.88M | 2.45% | 250,000 +57,657 | +30% | +$1.35M |
|
21
Danaher
DHR
$147B
| $5.78M | 2.42% | 25,000 -2,500 | -9% | -$578K |
|
|
22
Abbott
ABT
$231B
| $5.78M | 2.41% | +52,500 | New | +$5.78M |
|
23
Insulet
PODD
$23.9B
| $5.75M | 2.4% | 26,500 +6,500 | +33% | +$1.41M |
|
|
24
Inspire Medical Systems
INSP
$2.77B
| $5.59M | 2.34% | +27,500 | New | +$5.59M |
|
25
BioMarin Pharmaceuticals
BMRN
$11.2B
| $5.3M | 2.22% | 55,000 +5,000 | +10% | +$482K |
|